mni-815
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2015 (NCT02531360)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Microtubule-associated protein tauBINDING AGENT
MAPT binding agent
Chemistry & pharmacology
Loading structure…
SMILES
CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])cc2)cc1- Mol. weight
- 358.44 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Prescription Only
- Imaging
- 18-fluorine
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL566752 ↗
Also known as
- [18f]florbetaben
- mni-815
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02531360 | Early Phase 1 (Phase 1) | May 1, 2015 | Molecular NeuroImaging, Piramal |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Molecular NeuroImaging | For profit | 1 | 1 | 1 | 2015 |
| Piramal | For profit | 1 | 0 | 1 | 2015 |
2 organizations
Page 1 / 1